Is it possible for fenbendazole, which to my knowledge has to be ingested, to treat a surface cancer such as skin melanoma?
Research into fenbendazole's potential as an anticancer agent, particularly for skin cancer like melanoma, has shown some intriguing results, though it remains largely experimental and not yet approved for such use in humans.
A study mentioned that fenbendazole has shown an ability to inhibit the negative regulators of the P53 gene—a known tumor suppressor—and to promote its upregulation in melanoma cells. P53 gene plays a critical role in controlling cell growth and apoptosis, thus its activation could help suppress tumor growth and proliferation.
Moreover, there have been specific studies indicating that fenbendazole can induce apoptosis in melanoma cells, even those that are resistant to other treatments. This suggests a potential for fenbendazole to be used in cases where traditional therapies have failed. However, these studies are mostly preclinical, conducted in animal models or in vitro, and thus far from conclusive for general clinical application in humans.
It is important to approach these findings with caution as the efficacy and safety of fenbendazole for cancer treatment in humans remain under-researched and not officially sanctioned by medical regulatory bodies. Patients interested in exploring unconventional treatments like fenbendazole should do so under the guidance of a healthcare provider.
Heal Navigator is the largest resource for alternative cancer clinics and alternative cancer treatments. Learn more about us here.
Top Alternative Treatments
Join Our Newsletter